186 related articles for article (PubMed ID: 23517368)
1. Alemtuzumab is effective against severe chronic lymphocytic leukaemia-associated paraneoplastic pemphigus.
Bech R; Baumgartner-Nielsen J; Peterslund NA; Steiniche T; Deleuran M; d'Amore F
Br J Dermatol; 2013 Aug; 169(2):469-72. PubMed ID: 23517368
[TBL] [Abstract][Full Text] [Related]
2. Alemtuzumab-induced remission of both severe paraneoplastic pemphigus and leukaemic bone marrow infiltration in a case of treatment-resistant B-cell chronic lymphocytic leukaemia.
Hohwy T; Bang K; Steiniche T; Peterslund NA; d'Amore F
Eur J Haematol; 2004 Sep; 73(3):206-9. PubMed ID: 15287918
[TBL] [Abstract][Full Text] [Related]
3. Paraneoplastic pemphigus associated with chronic lymphocytic leukaemia: treatment with alemtuzumab.
Ekbäck M; Uggla B
Leuk Res; 2012 Aug; 36(8):e190-1. PubMed ID: 22579369
[No Abstract] [Full Text] [Related]
4. Successful treatment of paraneoplastic pemphigus in follicular NHL with rituximab: report of a case and review of treatment for paraneoplastic pemphigus in NHL and CLL.
Heizmann M; Itin P; Wernli M; Borradori L; Bargetzi MJ
Am J Hematol; 2001 Feb; 66(2):142-4. PubMed ID: 11421295
[TBL] [Abstract][Full Text] [Related]
5. Paraneoplastic Pemphigus Associated with B-cell Chronic Lymphocytic Leukemia Treated with Ibrutinib and Rituximab.
Ito Y; Makita S; Maeshima AM; Hatta S; Suzuki T; Yuda S; Fukuhara S; Munakata W; Suzuki T; Maruyama D; Izutsu K
Intern Med; 2018 Aug; 57(16):2395-2398. PubMed ID: 29526963
[TBL] [Abstract][Full Text] [Related]
6. Using rituximab (anti-CD20 antibody) in a patient with paraneoplastic pemphigus.
Schadlow MB; Anhalt GJ; Sinha AA
J Drugs Dermatol; 2003 Oct; 2(5):564-7. PubMed ID: 14558407
[TBL] [Abstract][Full Text] [Related]
7. A novel case of IgA paraneoplastic pemphigus associated with chronic lymphocytic leukemia.
Taintor AR; Leiferman KM; Hashimoto T; Ishii N; Zone JJ; Hull CM
J Am Acad Dermatol; 2007 May; 56(5 Suppl):S73-6. PubMed ID: 17434044
[TBL] [Abstract][Full Text] [Related]
8. [Paraneoplastic pemphigus: a pustular form during chronic lymphoid leukemia].
Rivollier C; Vaillant L; Machet MC; Martin L; Jan V; Huttenberger B; Joly P; Lorette G
Ann Dermatol Venereol; 2001 May; 128(5):644-8. PubMed ID: 11427801
[TBL] [Abstract][Full Text] [Related]
9. Paraneoplastic pemphigus associated with chronic lymphocytic leukemia: A case report.
Jiang Q; Zhang BH
Medicine (Baltimore); 2017 Feb; 96(8):e6184. PubMed ID: 28225504
[TBL] [Abstract][Full Text] [Related]
10. Successful use of Bruton's kinase inhibitor, ibrutinib, to control paraneoplastic pemphigus in a patient with paraneoplastic autoimmune multiorgan syndrome and chronic lymphocytic leukaemia.
Lee A; Sandhu S; Imlay-Gillespie L; Mulligan S; Shumack S
Australas J Dermatol; 2017 Nov; 58(4):e240-e242. PubMed ID: 28295171
[TBL] [Abstract][Full Text] [Related]
11. Paraneoplastic pemphigus. A report of two cases associated with chronic B-cell lymphocytic leukaemia.
Marzano AV; Grammatica A; Cozzani E; Terracina M; Berti E
Br J Dermatol; 2001 Jul; 145(1):127-31. PubMed ID: 11453921
[TBL] [Abstract][Full Text] [Related]
12. Chronic lymphocytic leukemia-associated paraneoplastic pemphigus: potential cause and therapeutic strategies.
Cao L; Wang F; Du XY; Zhu HY; Wang L; Xu W; Li JY; Fan L
Sci Rep; 2020 Oct; 10(1):16357. PubMed ID: 33004832
[TBL] [Abstract][Full Text] [Related]
13. Paraneoplastic pemphigus associated with chronic lymphocytic leukemia: a case report.
Konichi-Dias RL; Ramos AF; de Almeida Santos Yamashita ME; Cárcano CBM
J Med Case Rep; 2018 Aug; 12(1):252. PubMed ID: 30165900
[TBL] [Abstract][Full Text] [Related]
14. Paraneoplastic pemphigus treated with dexamethasone/ cyclophosphamide pulse therapy.
Becker LR; Bastian BC; Wesselmann U; Karl S; Hamm H; Bröcker EB
Eur J Dermatol; 1998 Dec; 8(8):551-3. PubMed ID: 9889426
[TBL] [Abstract][Full Text] [Related]
15. Paraneoplastic pemphigus as a presentation of acute myeloid leukemia: Early diagnosis and remission.
Siddiqui S; Bilal M; Otaibi Z; Bilimoria F; Patel N; Rossetti J
Hematol Oncol Stem Cell Ther; 2017 Sep; 10(3):155-160. PubMed ID: 27352260
[TBL] [Abstract][Full Text] [Related]
16. Therapy of paraneoplastic pemphigus with Rituximab: a case report and review of literature.
Barnadas M; Roe E; Brunet S; Garcia P; Bergua P; Pimentel L; Puig L; Francia A; García R; Gelpí C; Sierra J; Coll P; Alomar A
J Eur Acad Dermatol Venereol; 2006 Jan; 20(1):69-74. PubMed ID: 16405612
[TBL] [Abstract][Full Text] [Related]
17. [Paraneoplastic pemphigus in chronic lymphocytic leukemia].
Fournier B; Bouscarat F; Le Bozec P; Joly P; Gardin P; Grossin M; Descamps V; Crickx B; Belaïch S
Ann Dermatol Venereol; 1996; 123(8):483-6. PubMed ID: 9033721
[TBL] [Abstract][Full Text] [Related]
18. Paraneoplastic pemphigus in a patient with non-Hodgkin's lymphoma.
Plumb R; Doolittle GC
Am J Hematol; 1996 May; 52(1):58-9. PubMed ID: 8638613
[TBL] [Abstract][Full Text] [Related]
19. Paraneoplastic pemphigus characterized by polymorphic oral mucosal manifestations--report of two cases.
Yan Z; Hua H; Gao Y
Quintessence Int; 2010 Sep; 41(8):689-694. PubMed ID: 20657859
[TBL] [Abstract][Full Text] [Related]
20. Paraneoplastic pemphigus: a case report and review of literature.
Tilakaratne W; Dissanayake M
Oral Dis; 2005 Sep; 11(5):326-9. PubMed ID: 16120122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
